October 25, 2014 1:44 AM ET

Biotechnology

Company Overview of rEVO Biologics, Inc.

Executive Profile

Ashley Lawton Ph.D., MBA

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background

Mr. Ashley Lawton, Ph.D., MBA, served as Vice President of Business Development of GTC Biotherapeutics Inc. Dr. Lawton has over 20 years of business development and management experience in the biotechnology and pharmaceutical industries in senior positions at Celltech Biologics, Inc., RepliGen Corporation, and Genzyme Corporation. He served as the President and Chief Executive Officer of Phylos. His business development experience includes collaborative partnerships, ...

Corporate Headquarters

175 Crossing Boulevard
Framingham, Massachusetts 01702

United States

Phone: 508-620-9700
Fax: 508-370-3797

Board Members Memberships

Former Director

Education

PhD
University of Southampton

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact rEVO Biologics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.